Partner Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$708K Sell
10,898
-17,604
-62% -$1.15M 5.08% 4
2019
Q3
$1.81M Buy
28,502
+7,400
+35% +$484K 3.09% 7
2019
Q2
$1.43M Buy
+21,102
New +$1.39M 1.51% 20
2016
Q2
Sell
-17,379
Closed -$1.6M 87
2016
Q1
$1.6M Buy
17,379
+16,446
+1,763% +$1.48M 2.6% 12
2015
Q4
$94K Sell
933
-21,750
-96% -$2.26M 0.15% 59
2015
Q3
$2.23M Buy
+22,683
New +$2.52M 3.37% 7
2015
Q2
Sell
-11,863
Closed -$1.16M 98
2015
Q1
$1.16M Sell
11,863
-49,468
-81% -$5.02M 1.75% 21
2014
Q4
$5.78M Buy
61,331
+8,990
+17% +$930K 2.36% 12
2014
Q3
$5.57M Sell
52,341
-46,510
-47% -$4.55M 2.04% 22
2014
Q2
$8.2M Sell
98,851
-74,355
-43% -$5.79M 1.64% 26
2014
Q1
$12.3M Sell
173,206
-145,040
-46% -$11.4M 2.26% 16
2013
Q4
$23.9M Sell
318,246
-137,236
-30% -$9.56M 5.42% 4
2013
Q3
$28.6M Sell
455,482
-167,913
-27% -$10M 7.63% 1
2013
Q2
$32M Buy
+623,395
New +$32.5M 7.23% 1

Other funds holding GILD

Partner Investment Management's GILD Position: Q4 2019 in Review

Partner Investment Management reduced its Gilead Sciences (GILD) stake by 62% in Q4 2019, selling an estimated $1.15M and leaving 10,898 shares worth $708K. The position accounts for 5.08% of the portfolio, ranked #4.

Partner Investment Management first reported a position in GILD in Q2 2013 and has held it in 14 quarters since. The position peaked at $32M in Q2 2013. 1,557 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

  • Partner Investment Management held 10,898 shares of Gilead Sciences worth $708K as of Q4 2019.
  • Partner Investment Management sold 17,604 Gilead Sciences shares in Q4 2019, an estimated $1.15M.
  • Gilead Sciences made up 5.08% of Partner Investment Management's portfolio in Q4 2019, its #4 holding.
  • Partner Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 14 quarters since.
  • Partner Investment Management's Gilead Sciences position peaked at $32M in Q2 2013.
  • 1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.